This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Feb;53(2):705-8.

doi: 10.1002/hep.24137.

Survival of the fittest: selection of hepatitis C virus variants during liver graft reinfection

Ingmar Mederacke¹, Thomas Von Hahn

Affiliations

PMID: 21274891
DOI: 10.1002/hep.24137

Comment

Survival of the fittest: selection of hepatitis C virus variants during liver graft reinfection

Ingmar Mederacke et al. Hepatology. 2011 Feb.

. 2011 Feb;53(2):705-8.

doi: 10.1002/hep.24137.

Authors

Ingmar Mederacke¹, Thomas Von Hahn

Affiliation

¹ Department of Gastroenterology Hepatology, and Endocrinology Hannover Medical School Hannover, Germany.

PMID: 21274891
DOI: 10.1002/hep.24137

No abstract available

PubMed Disclaimer

Comment on

Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation.
Fafi-Kremer S, Fofana I, Soulier E, Carolla P, Meuleman P, Leroux-Roels G, Patel AH, Cosset FL, Pessaux P, Doffoël M, Wolf P, Stoll-Keller F, Baumert TF. Fafi-Kremer S, et al. J Exp Med. 2010 Aug 30;207(9):2019-31. doi: 10.1084/jem.20090766. Epub 2010 Aug 16. J Exp Med. 2010. PMID: 20713596 Free PMC article.

Similar articles

Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW. Saab S, et al. Liver Transpl. 2009 Nov;15(11):1525-34. doi: 10.1002/lt.21882. Liver Transpl. 2009. PMID: 19877207
Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC, Yan LN, Li B, Wen TF, Zhao JC, Cheng NS, Liu C, Liu J, Wang XB, Li XD, Qin S, Zhao LS, Lei BJ, Zhang XH. Lu SC, et al. Hepatobiliary Pancreat Dis Int. 2004 Feb;3(1):26-32. Hepatobiliary Pancreat Dis Int. 2004. PMID: 14969833 Clinical Trial.
[Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
Lucena JF, Herrero JI. Lucena JF, et al. An Sist Sanit Navar. 2004;27 Suppl 2:91-101. An Sist Sanit Navar. 2004. PMID: 15381947 Review. Spanish.
Recurrent disease after liver transplantation.
Davern TJ, Lake JR. Davern TJ, et al. Semin Gastrointest Dis. 1998 Jul;9(3):86-109. Semin Gastrointest Dis. 1998. PMID: 9700841 Review.
Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.
Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, Han S, Farmer DG, Yersiz H, Goldstein LI, Ghobrial RM, Busuttil RW. Saab S, et al. Liver Transpl. 2003 Oct;9(10):1053-61. doi: 10.1053/jlts.2003.50208. Liver Transpl. 2003. PMID: 14526400

See all similar articles

Cited by

Entry inhibitors: New advances in HCV treatment.
Qian XJ, Zhu YZ, Zhao P, Qi ZT. Qian XJ, et al. Emerg Microbes Infect. 2016 Jan 6;5(1):e3. doi: 10.1038/emi.2016.3. Emerg Microbes Infect. 2016. PMID: 26733381 Free PMC article. Review.
Entry Inhibitors of Hepatitis C Virus.
Qian XJ, Qi ZT. Qian XJ, et al. Adv Exp Med Biol. 2022;1366:207-222. doi: 10.1007/978-981-16-8702-0_13. Adv Exp Med Biol. 2022. PMID: 35412143

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley